Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, placebo-controlled study of Fentanyl Ethypharm for breakthrough pain in opioid-treated patients with cancer
2011-001140-30Phase 3Completed
- Sponsor
- Ethypharm
- Start
- May 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breakthrough cancer pain (BTcP) and cancer pain comparing Fentanyl Ethypharm with Placebo (2 arms). Primary endpoint: Pain Intensity. Started May 2011; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough cancer pain (BTcP)cancer pain
Beyond the preview
Go deeper on 2011-001140-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001140-30.